BRCA2 c.487_488del ;(p.S163Ffs*19)

Variant ID: 13-32900388-GGA-G

NM_000059.3(BRCA2):c.487_488del;(p.S163Ffs*19)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy.

Breast Cancer Research And Treatment
Ellingson, Marissa S MS; Hart, Steven N SN; Kalari, Krishna R KR; Suman, Vera V; Schahl, Kimberly A KA; Dockter, Travis J TJ; Felten, Sara J SJ; Sinnwell, Jason P JP; Thompson, Kevin J KJ; Tang, Xiaojia X; Vedell, Peter T PT; Barman, Poulami P; Sicotte, Hugues H; Eckel-Passow, Jeanette E JE; Northfelt, Donald W DW; Gray, Richard J RJ; McLaughlin, Sarah A SA; Moreno-Aspitia, Alvaro A; Ingle, James N JN; Moyer, Ann M AM; Visscher, Daniel W DW; Jones, Katie K; Conners, Amy A; McDonough, Michelle M; Wieben, Eric D ED; Wang, Liewei L; Weinshilboum, Richard R; Boughey, Judy C JC; Goetz, Matthew P MP
Publication Date: 2015-09

Variant appearance in text: BRCA2: 487_488delAG
PubMed Link: 26296701
Variant Present in the following documents:
  • Main text
  • 10549_2015_Article_3545.pdf
View BVdb publication page